%0 Journal Article
%T Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease
%A Anita B¨˘lint
%A Anna F¨˘bi¨˘n
%A Ferenc Nagy
%A Klaudia Farkas
%A Mariann Rutka
%A M¨˘ria Matuz
%A Ren¨˘ta Bor
%A Tam¨˘s Moln¨˘r
%A Zolt¨˘n Szepes
%A ¨˘gnes Milassin
%J Archive of "PLoS ONE".
%D 2017
%R 10.1371/journal.pone.0172916
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376081/